RJ Hamster
🌎 Rivian Automotive Upgraded, Wells Fargo & Company Upgraded,…
Ratings changes for Applied Materials, Rivian Automotive, Roku, JFrog, Pilgrim’s Pride, Immunic, CRISPR Therapeutics and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
FEBRUARY 13TH, 2026
ISPC: A Small Cap Disrupting the $4B Biospecimen Market! (ad)Every breakthrough in precision medicine, diagnostics, and drug development relies on high-quality human biospecimens. Yet today’s supply chain is slow, fragmented, and relationship-driven. Researchers often wait 6 to 12 months just to secure sourcing agreements, facing delays, inconsistent availability, and complex compliance hurdles. Meanwhile, hospitals and labs struggle to monetize specimens they already collect. iSpecimen Inc. (NASDAQ: ISPC) is quietly revolutionizing this broken system through its cloud-based iSpecimen Marketplace, connecting life science researchers directly with providers through a compliant, searchable, global platform. The global biospecimen market is estimated at $3 to $4 billion and growing 10 to 15% annually. As a first-mover with a scalable, cloud-based marketplace, ISPC is uniquely positioned to capture market share. In early 2026, ISPC sourced 500 influenza swab samples in just weeks for a time-sensitive research project. With 105+ supplier organizations, 600+ unique customer organizations, and nearly 7,600 marketplace users, ISPC is building the infrastructure that modern biomedical research needs.
SEE WHY ISPC IS TRANSFORMING BIOSPECIMEN ACCESS IN A $4 BILLION MARKET
Today’s Top Stories
It’s Not Too Late to Buy These 2 Red-Hot AI Infrastructure Stocks
BY RYAN HASSON | FEBRUARY 13, 2026 08:30 AM
What do Amazon, Microsoft, and Elon Musk’s xAI have in common? (Ad)
BY TRADINGTIPS
Is AI Really Eating Software? A Wall Street Veteran Says No—Here’s Why
BY BRIDGET BENNETT | FEBRUARY 13, 2026 08:00 AM
Unity’s Stock Plunges 30%: Panic? Or Profit?
BY JEFFREY NEAL JOHNSON | FEBRUARY 12, 2026 04:06 PM
5 Stocks Under $5 (Ad)
BY TRADINGTIPS
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
BY NATHAN REIFF | FEBRUARY 12, 2026 12:26 PM
2 Reasons Qualcomm’s Risk/Reward Is Now Red Hot
BY SAM QUIRKE | FEBRUARY 12, 2026 08:34 AM
Quick Links
Analyst RatingsMy MarketBeatAccount SettingsMarketBeat All AccessStock ListsStock ScreenerCalculatorsPremium ReportsBest Stocks to Buy in FebruaryISPC: A Must-Watch Life Sciences Stock (ad)iSpecimen Inc. (NASDAQ: ISPC)’s cloud-based marketplace is transforming access to critical human specimens for life science research. By linking over 600 customer organizations to more than 105 global supplier organizations, the platform provides fast, compliant, and reliable biospecimen sourcing. Researchers can quickly find samples by disease state, demographics, or processing method, while hospitals and labs gain revenue opportunities from specimens that would otherwise go unused. ISPC has already demonstrated its ability to deliver under tight timelines, sourcing hundreds of influenza swab samples for time-sensitive studies in just weeks. With a scalable marketplace, strong operational execution, and strategic partnerships expanding platform capabilities, ISPC is positioned to capture a growing share of a high-growth market. A financial approach that supports long-term flexibility complements its operational progress.
SEE WHY ISPC IS EMERGING AS A MUST-WATCH SMALL-CAP BIOSPECIMEN PLATFORM
Your Watchlist
MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO
$259.83 -1.90 (-0.73%) As of 2/13/2026 9:42 AM ET
- Almost 17% of Berkshire Hathaway’s $328 Billion Portfolio Is Invested in 1 Top Stock That’s Up 180% in 5 Years 2/13 – FOOL
- Apple (AAPL) Stock Tumbles 5% on Siri Setback and Regulatory Heat2/13 – BLOCKONOMI
- Amazon Joins Microsoft in Bear Market. Why Mag 7 Stocks Are Struggling.2/13 – BARRONS
- Smithbridge Asset Management Inc. DE Has $39.47 Million Holdings in Apple Inc. $AAPLÂ 2/13 – MARKETBEAT
- Meitav Investment House Ltd. Raises Stock Position in Apple Inc. $AAPL2/13 – MARKETBEAT
$197.98 -1.63 (-0.81%) As of 2/13/2026 9:42 AM ET
- Trek Financial LLC Raises Stake in Amazon.com, Inc. $AMZNÂ 2/13 – MARKETBEAT
- The Last 2 Times Amazon’s RSI Did This, the Stock Rallied 60% 2/13 – MARKETBEAT
- Microsoft, Alphabet, Amazon, and Meta Platforms Just Announced Fantastic News for Nvidia. 2/13 – FOOL
- Amazon Just Achieved This Major Milestone That Only 1 Other Company Has Done Since 2001Â 2/13 – FOOL
- Pershing’s Ackman Reveals New Stakes in Meta, Amazon, and Hertz 2/13 – BARRONS
$304.05 -4.95 (-1.60%) As of 2/13/2026 9:42 AM ET
- Amazon Joins Microsoft in Bear Market. Why Mag 7 Stocks Are Struggling.2/13 – BARRONS
- Alphabet Inc. $GOOGL Shares Bought by SYM FINANCIAL Corp 2/13 – MARKETBEAT
- Private Wealth Asset Management LLC Has $6.33 Million Holdings in Alphabet Inc. $GOOGLÂ 2/13 – MARKETBEAT
- The Zacks Analyst Alphabet, Caterpillar,T-Mobile US and Onfolio 2/13 – ZACKS
- Waymo is paying DoorDash gig workers to close its robotaxi doors 2/12 – CNBC
$635.26 -14.55 (-2.24%) As of 2/13/2026 9:42 AM ET
- Meta Platforms, Inc. (NASDAQ:META) declared a quarterly dividend on Thursday, February 12th. Stockholders of record on Monday, March 16th will be given a dividend of 0.525 per share by the social networking company on Thursday, March 26th. This represents a c) annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, March 16th.
- Amazon Joins Microsoft in Bear Market. Why Mag 7 Stocks Are Struggling.2/13 – BARRONS
- Billionaire Bill Ackman Just Dumped Chipotle for Meta: Should You Follow His Lead? 2/13 – 247WALLST
- Wall Street Sees 29% Upside for Meta While Retail Investors Turn Skeptical2/13 – 247WALLST
- Meta Platforms, Inc. $META Shares Sold by Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTDÂ 2/13 – MARKETBEAT
- Meta Platforms, Inc. $META Shares Sold by Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTDÂ 2/13 – MARKETBEAT
$400.70 -1.14 (-0.28%) As of 2/13/2026 9:42 AM ET
- Leading bank calls AI threat to enterprise software “illogical,” upgrades five stocks for 2026Â 2/13 – PROACTIVEINVESTORS
- OpenAI’s $588B Problem Just Made Microsoft Irresistible 2/13 – SEEKINGALPHA
- Why Microsoft Stock Is A Bargain At $4002/13 – FORBES
- Amazon Joins Microsoft in Bear Market. Why Mag 7 Stocks Are Struggling.2/13 – BARRONS
- Vaughan David Investments LLC IL Sells 13,044 Shares of Microsoft Corporation $MSFTÂ 2/13 – MARKETBEAT
Analysts’ Upgrades
Applied Materials (NASDAQ:AMAT) was upgraded by analysts at Summit Insights from a “hold” rating to a “buy” rating.The current price is $369.18.Chagee (NASDAQ:CHA) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $11.50 price target on the stock. This represents a 13.0% upside from the current price of $10.18.Freeport-McMoRan (NYSE:FCX) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating.The current price is $60.48.International Flavors & Fragrances(NYSE:IFF) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $97.00 price target on the stock. This represents a 19.2% upside from the current price of $81.38.McDonald’s (NYSE:MCD) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $380.00 price target on the stock. This represents a 13.4% upside from the current price of $335.08.Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating. They now have a $150.00 price target on the stock. This represents a 22.3% upside from the current price of $122.70.Cloudflare (NYSE:NET) was upgraded by analysts at DZ Bank AG from a “hold” rating to a “buy” rating. They now have a $215.00 price target on the stock. This represents a 15.8% upside from the current price of $185.74.Rivian Automotive (NASDAQ:RIVN) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating. They now have a $23.00 price target on the stock, up previously from $16.00. This represents a 36.3% upside from the current price of $16.87.Roku (NASDAQ:ROKU) was upgraded by analysts at Rosenblatt Securities from a “neutral” rating to a “buy” rating. They now have a $118.00 price target on the stock, up previously from $106.00. This represents a 29.4% upside from the current price of $91.22.Rayonier (NYSE:RYN) was upgraded by analysts at Raymond James Financial, Inc. from an “outperform” rating to a “strong-buy” rating. They now have a $28.00 price target on the stock, up previously from $26.00. This represents a 20.1% upside from the current price of $23.32.SPX Technologies (NYSE:SPXC) was upgraded by analysts at Bank of America Corporation from a “neutral” rating to a “buy” rating. They now have a $280.00 price target on the stock, up previously from $240.00. This represents a 18.7% upside from the current price of $235.86.Synchrony Financial (NYSE:SYF) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $83.00 price target on the stock. This represents a 17.6% upside from the current price of $70.56.Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $540.00 price target on the stock. This represents a 11.6% upside from the current price of $483.69.Wells Fargo & Company (NYSE:WFC) was upgraded by analysts at Robert W. Baird from an “underperform” rating to a “neutral” rating. They now have a $85.00 price target on the stock. This represents a 0.7% downside from the current price of $85.62.Williams Companies (NYSE:WMB) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating. They now have a $84.00 price target on the stock. This represents a 18.0% upside from the current price of $71.22.Warner Music Group (NASDAQ:WMG) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating.The current price is $28.87.
VIEW MORE UPGRADES
BNZI: Triple-Digit Growth, Zacks Approved! (ad)Banzai International (NASDAQ: BNZI) just earned a Zacks Rank #2 (Buy), placing it in the top 20% of over 4,000 tracked stocks. The Zacks Consensus Estimate for BNZI’s full-year earnings has surged 45.2% in three months, signaling rapidly improving analyst sentiment. BNZI provides AI-powered marketing and business automation tools to over 140,000 customers worldwide, including Cisco, Hewlett Packard, and Thermo Fisher Scientific.See why
BNZI EARNED A ZACKS BUY RATING WITH SURGING ESTIMATES
Analysts’ Downgrades
Fortune Brands Innovations (NYSE:FBIN) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $55.00 price target on the stock. This represents a 5.0% upside from the current price of $52.37.Norwegian Cruise Line (NYSE:NCLH) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $20.00 price target on the stock. This represents a 5.3% downside from the current price of $21.11.Ormat Technologies (NYSE:ORA) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $130.00 price target on the stock. This represents a 10.2% upside from the current price of $118.00.Pinterest (NYSE:PINS) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $20.00 price target on the stock. This represents a 38.9% upside from the current price of $14.40.AB Volvo (OTCMKTS:VLVLY) was downgraded by analysts at Royal Bank Of Canada from an “outperform” rating to a “sector perform” rating.The current price is $39.00.
VIEW MORE DOWNGRADES
BNZI Is Winning Wall Street Attention. (ad)Researchers often wait 6 to 12 months to secure biospecimen sourcing agreements. iSpecimen (NASDAQ: ISPC) is fixing this broken system with its cloud-based marketplace that provides next-day access to high-quality samples. With 600+ customer organizations and 105+ suppliers, ISPC recently sourced 500 influenza swab samples in just weeks for time-sensitive research.
SEE HOW ISPC IS ACCELERATING BIOMEDICAL RESEARCH TIMELINES
Analysts’ New Coverage
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $15.00 price target on the stock. This represents a 130.1% upside from the current price of $6.52.
VIEW MORE NEW COVERAGE
Calendars from MarketBeat
U.S. Analyst RatingsCongressional BuyingCorporate BuybacksCryptocurrenciesDividend DeclarationsEarnings AnnouncementsEarnings Conference CallsFDA CalendarGap Up/Down StocksInsider TradesInitial Public Offerings (IPOs)Most Active StocksPercentage Gainers/DeclinersSector PerformanceShort InterestStock SplitsUnusual Options VolumeUnusual Trading VolumeGET 30 DAYS OF MARKETBEAT ALL ACCESS FREESign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
- Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
- Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
- Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.Â
Thank you for subscribing to MarketBeat!
MarketBeat empowers individual investors to make better financial decisions by delivering real-time financial information and unbiased market analysis.
If you have questions or concerns about your newsletter, feel free to email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you want to opt out or change which newsletters you receive, you can update your subscription preferencesor unsubscribe from this newsletter.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place #620, Sioux Falls, South Dakota 57103-7078. United States of America..
Daily Bonus Content: ISPC: From Microcap to Major Player? (From Stocks.News)
